Search research articles
Contact Us
Filters
Showing results (61-70 of 80) with videos related to
Page
of 8
Sort By:
Blood
|
January 1, 1987
The cellular basis for different fetal hemoglobin levels among sickle cell individuals with two, three, and four alpha-globin genes
G J Dover, V T Chang, S H Boyer, et al.
The American Journal of Pediatric Hematology/Oncology
|
February 1, 1994
Butyrate derivatives. New agents for stimulating fetal globin production in the beta-globin disorders
S P Perrine, N F Olivieri, D V Faller, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 1, 1984
Origin of the beta S-globin gene in blacks: the contribution of recurrent mutation or gene conversion or both
S E Antonarakis, C D Boehm, G R Serjeant, et al.
British Journal of Haematology
|
September 21, 2001
The role of heterocellular hereditary persistence of fetal haemoglobin in beta(0)-thalassaemia intermedia
Y P Chang, R Littera, R Garau, et al.
Experimental Hematology
|
November 1, 1992
Hydroxyurea-induced HbF production in anemic primates: augmentation by erythropoietin, hematopoietic growth factors, and sodium butyrate
K T McDonagh, G J Dover, R E Donahue, et al.
Blood
|
March 1, 1986
Hydroxyurea induction of hemoglobin F production in sickle cell disease: relationship between cytotoxicity and F cell production
G J Dover, R K Humphries, J G Moore, et al.
The New England Journal of Medicine
|
November 16, 1989
Normal fetal hemoglobin levels in the sudden infant death syndrome
H R Zielke, R G Meny, M J O'Brien, et al.
Blood
|
August 1, 1992
Fetal hemoglobin levels in sickle cell disease and normal individuals are partially controlled by an X-linked gene located at Xp22.2
G J Dover, K D Smith, Y C Chang, et al.
Blood
|
December 15, 1992
Trial of recombinant human erythropoietin: three patients with thalassemia intermedia
N F Olivieri, M H Freedman, S P Perrine, et al.
Journal of Pediatric Hematology/Oncology
|
November 5, 1997
Successful treatment of life-threatening acute chest syndrome of sickle cell disease with venovenous extracorporeal membrane oxygenation
M A Pelidis, G J Kato, L M Resar, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 80) with videos related to
Sort By:
Page
of 8
Blood
|
January 1, 1987
The cellular basis for different fetal hemoglobin levels among sickle cell individuals with two, three, and four alpha-globin genes
G J Dover, V T Chang, S H Boyer, et al.
The American Journal of Pediatric Hematology/Oncology
|
February 1, 1994
Butyrate derivatives. New agents for stimulating fetal globin production in the beta-globin disorders
S P Perrine, N F Olivieri, D V Faller, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 1, 1984
Origin of the beta S-globin gene in blacks: the contribution of recurrent mutation or gene conversion or both
S E Antonarakis, C D Boehm, G R Serjeant, et al.
British Journal of Haematology
|
September 21, 2001
The role of heterocellular hereditary persistence of fetal haemoglobin in beta(0)-thalassaemia intermedia
Y P Chang, R Littera, R Garau, et al.
Experimental Hematology
|
November 1, 1992
Hydroxyurea-induced HbF production in anemic primates: augmentation by erythropoietin, hematopoietic growth factors, and sodium butyrate
K T McDonagh, G J Dover, R E Donahue, et al.
Blood
|
March 1, 1986
Hydroxyurea induction of hemoglobin F production in sickle cell disease: relationship between cytotoxicity and F cell production
G J Dover, R K Humphries, J G Moore, et al.
The New England Journal of Medicine
|
November 16, 1989
Normal fetal hemoglobin levels in the sudden infant death syndrome
H R Zielke, R G Meny, M J O'Brien, et al.
Blood
|
August 1, 1992
Fetal hemoglobin levels in sickle cell disease and normal individuals are partially controlled by an X-linked gene located at Xp22.2
G J Dover, K D Smith, Y C Chang, et al.
Blood
|
December 15, 1992
Trial of recombinant human erythropoietin: three patients with thalassemia intermedia
N F Olivieri, M H Freedman, S P Perrine, et al.
Journal of Pediatric Hematology/Oncology
|
November 5, 1997
Successful treatment of life-threatening acute chest syndrome of sickle cell disease with venovenous extracorporeal membrane oxygenation
M A Pelidis, G J Kato, L M Resar, et al.
Page
of 8